<![CDATA[Insights]]>https://insights.citeline.comMon, 04 Nov 2024 10:18:12 +0000en1hourly1<![CDATA[New EMA Fees Could Shake Up Pharma Submission Strategies]]>https://insights.citeline.com/pink-sheet/agency-leadership/ema/new-ema-fees-could-shake-up-pharma-submission-strategies-UJYLQHQJJRD35I7OAOBSHMQIQQ/https://insights.citeline.com/pink-sheet/agency-leadership/ema/new-ema-fees-could-shake-up-pharma-submission-strategies-UJYLQHQJJRD35I7OAOBSHMQIQQ/Fri, 01 Nov 2024 15:35:16 +0000<![CDATA[Teva Fined Half A Billion Dollars Over European Copaxone Antitrust Breach]]>https://insights.citeline.com/pink-sheet/biosimilars-and-generics/teva-fined-half-a-billion-dollars-over-european-copaxone-antitrust-breach-YEJ7BD5XM5DDBAEB4QH7LDS5ZQ/https://insights.citeline.com/pink-sheet/biosimilars-and-generics/teva-fined-half-a-billion-dollars-over-european-copaxone-antitrust-breach-YEJ7BD5XM5DDBAEB4QH7LDS5ZQ/Fri, 01 Nov 2024 15:45:57 +0000<![CDATA[EMA Seeks Feedback On COI Policy Changes Following Legal Rulings]]>https://insights.citeline.com/pink-sheet/geography/europe/ema-seeks-feedback-on-coi-policy-changes-following-legal-rulings-FYQ74YWPCBDBFM3ZX3YFZAWAZQ/https://insights.citeline.com/pink-sheet/geography/europe/ema-seeks-feedback-on-coi-policy-changes-following-legal-rulings-FYQ74YWPCBDBFM3ZX3YFZAWAZQ/Fri, 01 Nov 2024 15:05:58 +0000<![CDATA[The RFK ‘Wild’ Card: Uncertainty For US FDA In A Second Trump Term]]>https://insights.citeline.com/pink-sheet/legislation/elections/the-rfk-wild-card-uncertainty-for-us-fda-in-a-second-trump-term-VHBC3BHFGJBTVIANPFE3ZPNIKQ/https://insights.citeline.com/pink-sheet/legislation/elections/the-rfk-wild-card-uncertainty-for-us-fda-in-a-second-trump-term-VHBC3BHFGJBTVIANPFE3ZPNIKQ/Fri, 01 Nov 2024 17:56:30 +0000<![CDATA[US FDA’s New Rare Disease Hub Director Rick Brings Advocacy Experience ]]>https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-new-rare-disease-hub-director-rick-brings-advocacy-experience-QDFWZWICV5DM5IZUTVFIVQZLBQ/https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-new-rare-disease-hub-director-rick-brings-advocacy-experience-QDFWZWICV5DM5IZUTVFIVQZLBQ/Sat, 02 Nov 2024 02:05:00 +0000<![CDATA[Practical Matters: Rare Disease Advocates Want Help From US FDA Hub To Make Data Useful]]>https://insights.citeline.com/pink-sheet/rare-diseases/practical-matters-rare-disease-advocates-want-help-from-us-fda-hub-to-make-data-useful-WCTRXKH5SFD3HIPZG62CA2TIAA/https://insights.citeline.com/pink-sheet/rare-diseases/practical-matters-rare-disease-advocates-want-help-from-us-fda-hub-to-make-data-useful-WCTRXKH5SFD3HIPZG62CA2TIAA/Sat, 02 Nov 2024 02:02:00 +0000